Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1022150-12-4

Post Buying Request

1022150-12-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine CAS 1022150-12-4 In STOCK

    Cas No: 1022150-12-4

  • USD $ 1.0-1.0 / Metric Ton

  • 1 Metric Ton

  • 5 Metric Ton/Day

  • Chemwill Asia Co., Ltd.
  • Contact Supplier

1022150-12-4 Usage

Description

IBT6A is a Btk kinase inhibitor. This compound is a precurser for the manufacture of ibrutinib.

Uses

(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine is an intermediate used to prepare pyrazolo-pyrimidine compounds as inhibitors of Bruton''s tyrosine kinase. It is also an intermediate for Ibrutinib (I124970) derivatives.

Check Digit Verification of cas no

The CAS Registry Mumber 1022150-12-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,2,1,5 and 0 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1022150-12:
(9*1)+(8*0)+(7*2)+(6*2)+(5*1)+(4*5)+(3*0)+(2*1)+(1*2)=64
64 % 10 = 4
So 1022150-12-4 is a valid CAS Registry Number.
InChI:InChI=1S/C22H22N6O/c23-21-19-20(15-8-10-18(11-9-15)29-17-6-2-1-3-7-17)27-28(22(19)26-14-25-21)16-5-4-12-24-13-16/h1-3,6-11,14,16,24H,4-5,12-13H2,(H2,23,25,26)

1022150-12-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-ami ne

1.2 Other means of identification

Product number -
Other names (R)-3-(4-phenoxyphenyl)-1-(piperidine-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1022150-12-4 SDS

1022150-12-4Synthetic route

(3R)‐4‐amino‐3‐(4-phenoxyphenyl)‐1‐(1‐tert-butoxycarbonylpiperidine-3-yl)-1H-pyrazolo[3,4-d]pyrimidine
1022150-11-3

(3R)‐4‐amino‐3‐(4-phenoxyphenyl)‐1‐(1‐tert-butoxycarbonylpiperidine-3-yl)-1H-pyrazolo[3,4-d]pyrimidine

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane for 2h; Inert atmosphere;100%
With hydrogenchloride In methanol; water at 50℃;98%
With hydrogenchloride In methanol at 20℃; for 2h;92%
(3R)-3-[4-(benzyloxycarbonylamino)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylic acid benzyl ester

(3R)-3-[4-(benzyloxycarbonylamino)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylic acid benzyl ester

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With palladium on activated charcoal99%
4-phenoxyphenylboronic acid
51067-38-0

4-phenoxyphenylboronic acid

C10H13BrN6*2ClH

C10H13BrN6*2ClH

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With potassium phosphate; tetrakis(triphenylphosphine) palladium(0) In 1,4-dioxane; water for 5h; Solvent; Reagent/catalyst; Suzuki Coupling; Inert atmosphere; Reflux;90%
With potassium phosphate; tetrakis(triphenylphosphine) palladium(0) In 1,4-dioxane; water for 5h; Reagent/catalyst; Solvent; Suzuki Coupling; Inert atmosphere; Reflux;90%
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8

3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(S)-3-hydroxypiperidine-N-carboxylate methyl ester

(S)-3-hydroxypiperidine-N-carboxylate methyl ester

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate In tetrahydrofuran at 35℃; Inert atmosphere;88.6%
4-phenoxyphenylboronic acid
51067-38-0

4-phenoxyphenylboronic acid

3-bromo-1-[(3R)-piperidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine

3-bromo-1-[(3R)-piperidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With potassium phosphate; tetrakis(triphenylphosphine) palladium(0) In 1,2-dimethoxyethane; water for 5h; Suzuki Coupling; Inert atmosphere; Reflux;87.1%
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In 1,4-dioxane for 4h; Inert atmosphere; Reflux;0.5 g
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8

3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

N-tert-butoxycarbonyl-3-piperidinol
85275-45-2

N-tert-butoxycarbonyl-3-piperidinol

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With diethylazodicarboxylate In 1,4-dioxane at 20℃; Inert atmosphere;85.3%
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8

3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

tert-butyl (3S)-3-hydroxypiperidine-1-carboxylate
143900-44-1

tert-butyl (3S)-3-hydroxypiperidine-1-carboxylate

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 25℃; Temperature; Mitsunobu Displacement; Inert atmosphere; Large scale;85%
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 30℃; for 25h; Concentration; Temperature;80.45%
Stage #1: 3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; tert-butyl (3S)-3-hydroxypiperidine-1-carboxylate With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 5h; Mitsunobu Displacement;
Stage #2: With hydrogenchloride In tetrahydrofuran; water at 20℃; for 5h;
69%
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8

3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(S)-N-trifluoroacetyl-3-hydroxypiperidine
1126736-20-6

(S)-N-trifluoroacetyl-3-hydroxypiperidine

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Stage #1: 3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; (S)-N-trifluoroacetyl-3-hydroxypiperidine With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20 - 30℃; for 4.5h; Mitsunobu Displacement; Inert atmosphere;
Stage #2: With water; sodium hydroxide In methanol at 20 - 30℃; for 2h;
Stage #3: With hydrogenchloride In methanol; water at 45 - 55℃; for 3h;
84.8%
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8

3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(S)-3-hydroxypiperidine-N-carboxylate allyl ester

(S)-3-hydroxypiperidine-N-carboxylate allyl ester

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With azodicarboxylic acid diphenyl ester In ethyl acetate at 50℃; Inert atmosphere;81.3%
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8

3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(S)-3-hydroxypiperidine-N-carboxylate benzyl ester
94944-69-1

(S)-3-hydroxypiperidine-N-carboxylate benzyl ester

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With 2,2'-azobis(isobutyronitrile) In acetonitrile at 0℃; Inert atmosphere; Large scale;74.4%
(R)-1-(1-benzylpiperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-1-(1-benzylpiperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With hydrogen In methanol; water at 50℃; under 1034.32 Torr; for 2h; Acidic conditions;67.4%
With hydrogenchloride; 10 wt% Pd(OH)2 on carbon In methanol at 40 - 50℃;
With palladium 10% on activated carbon; hydrogen In methanol
4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidine
151266-23-8

4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidine

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: triphenylphosphine; di-isopropyl azodicarboxylate / tetrahydrofuran / 12.5 h / 10 - 20 °C
2: sodium carbonate / tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
3: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: triphenylphosphine; di-isopropyl azodicarboxylate / tetrahydrofuran / 72 h / 70 °C
2: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
3: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: caesium carbonate / N,N-dimethyl-formamide / 12 h / 60 °C
2: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
3: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
4-Aminopyrazolo<3,4-d>pyrimidin
2380-63-4

4-Aminopyrazolo<3,4-d>pyrimidin

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: N-iodo-succinimide / N,N-dimethyl-formamide / 5 h / 80 °C
2: triphenylphosphine; di-isopropyl azodicarboxylate / tetrahydrofuran / 12.5 h / 10 - 20 °C
3: sodium carbonate / tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
4: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: N-iodo-succinimide / N,N-dimethyl-formamide / 60 °C
2: caesium carbonate / N,N-dimethyl-formamide / 12 h / 60 °C
3: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
4: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: N-iodo-succinimide / N,N-dimethyl-formamide / 60 °C
2: triphenylphosphine; di-isopropyl azodicarboxylate / tetrahydrofuran / 72 h / 70 °C
3: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
4: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
(R)-3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylic acid tert-butyl ester
1276110-38-3

(R)-3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylic acid tert-butyl ester

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium carbonate / tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
2: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
2: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
2: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
tert-butyl (3S)-3-[[(4-methylbenzene)sulfonyl]oxy]piperidine-1-carboxylate
1353993-49-3

tert-butyl (3S)-3-[[(4-methylbenzene)sulfonyl]oxy]piperidine-1-carboxylate

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: caesium carbonate / N,N-dimethyl-formamide / 12 h / 60 °C
2: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
3: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: caesium carbonate / N,N-dimethyl-formamide / 12 h / 60 °C
2: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
3: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: caesium carbonate / N,N-dimethyl-formamide / 12 h / 60 °C
2: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
3: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
tert-butyl (3S)-3-hydroxypiperidine-1-carboxylate
143900-44-1

tert-butyl (3S)-3-hydroxypiperidine-1-carboxylate

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: pyridine / 5.5 h / 0 - 25 °C
2: caesium carbonate / N,N-dimethyl-formamide / 12 h / 60 °C
3: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
4: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: pyridine / 5.5 h / 0 - 25 °C
2: caesium carbonate / N,N-dimethyl-formamide / 12 h / 60 °C
3: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
4: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: pyridine / 5.5 h / 0 - 25 °C
2: caesium carbonate / N,N-dimethyl-formamide / 12 h / 60 °C
3: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
4: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
4-phenoxyphenylboronic acid
51067-38-0

4-phenoxyphenylboronic acid

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
2: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
2: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 24 h / 90 °C / Inert atmosphere
2: trifluoroacetic acid / dichloromethane / 12 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium carbonate / 1,4-dioxane; water / 80 °C / Inert atmosphere
2: trifluoroacetic acid / dichloromethane / 20 °C
View Scheme
C29H27N5O3

C29H27N5O3

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2-ethoxy-ethanol / 6 h / 120 °C
2: 10 wt% Pd(OH)2 on carbon; hydrogen / methanol / 55 - 60 °C / 2250.23 Torr
View Scheme
C30H28N6O3

C30H28N6O3

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With 10 wt% Pd(OH)2 on carbon; hydrogen In methanol at 55 - 60℃; under 2250.23 Torr;
C28H27N5O

C28H27N5O

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2-ethoxy-ethanol / 8 h / 20 - 120 °C / Inert atmosphere
2: hydrogenchloride; 10 wt% Pd(OH)2 on carbon / methanol / 40 - 50 °C
View Scheme
2-[(4-phenoxy-phenyl)-methoxy-methylene]-malononitrile
330792-69-3

2-[(4-phenoxy-phenyl)-methoxy-methylene]-malononitrile

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: triethylamine / ethanol; water / 1 h / 5 - 25 °C / Inert atmosphere
2: 2-ethoxy-ethanol / 6 h / 120 °C
3: 10 wt% Pd(OH)2 on carbon; hydrogen / methanol / 55 - 60 °C / 2250.23 Torr
View Scheme
Multi-step reaction with 3 steps
1: triethylamine / ethanol; water / 1 h / 5 - 30 °C / Inert atmosphere
2: 2-ethoxy-ethanol / 8 h / 20 - 120 °C / Inert atmosphere
3: hydrogenchloride; 10 wt% Pd(OH)2 on carbon / methanol / 40 - 50 °C
View Scheme
Multi-step reaction with 4 steps
1.1: hydrazine hydrate / ethanol / 1 h / Reflux
2.1: 8 h / 150 °C
3.1: potassium carbonate / N,N-dimethyl-formamide / 2 h / 21 - 22 °C
3.2: 14 h / 80 °C
4.1: hydrogenchloride / ethyl acetate / 0.5 h
View Scheme
C13H19N3O2*2ClH

C13H19N3O2*2ClH

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: triethylamine / ethanol; water / 1 h / 5 - 25 °C / Inert atmosphere
2: 2-ethoxy-ethanol / 6 h / 120 °C
3: 10 wt% Pd(OH)2 on carbon; hydrogen / methanol / 55 - 60 °C / 2250.23 Torr
View Scheme
(R)-tert-butyl 3-(5-amino-4-cyano-3-(4-phenoxyphenyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate
1612774-50-1

(R)-tert-butyl 3-(5-amino-4-cyano-3-(4-phenoxyphenyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2-ethoxy-ethanol / 8 h / 20 - 120 °C / Inert atmosphere
2: hydrogenchloride; methanol / 3 h / 50 °C
View Scheme
C12H19N3*2ClH

C12H19N3*2ClH

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: triethylamine / ethanol; water / 1 h / 5 - 30 °C / Inert atmosphere
2: 2-ethoxy-ethanol / 8 h / 20 - 120 °C / Inert atmosphere
3: hydrogenchloride; 10 wt% Pd(OH)2 on carbon / methanol / 40 - 50 °C
View Scheme
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8

3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: di-isopropyl azodicarboxylate / tetrahydrofuran / 0.17 h / Heating; Inert atmosphere
2: hydrogenchloride / 1,4-dioxane / 2 h / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1.1: triphenylphosphine; di-isopropyl azodicarboxylate / tetrahydrofuran / 1 h / 0 °C / Inert atmosphere
1.2: 12 h / 0 - 20 °C / Inert atmosphere
2.1: hydrogenchloride / water; ethyl acetate / 1 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: caesium carbonate / N,N-dimethyl-formamide / 12 h / 100 °C
2: hydrogenchloride / methanol / 2 h / 20 °C
View Scheme
2,6-dichloro-pyrimidine carbaldehyde
5305-40-8

2,6-dichloro-pyrimidine carbaldehyde

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: n-butyllithium / tetrahydrofuran / 1 h / -20 °C
1.2: 1 h / 0 °C
2.1: manganese(IV) oxide / dichloromethane / 5 h
3.1: ammonia / ethanol / 5 h / 0 °C
4.1: hydrazine hydrate / ethanol / 1 h / 20 °C
5.1: caesium carbonate / N,N-dimethyl-formamide / 12 h / 100 °C
6.1: hydrogenchloride / methanol / 2 h / 20 °C
View Scheme
4-Bromodiphenyl ether
101-55-3

4-Bromodiphenyl ether

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: n-butyllithium / tetrahydrofuran / 1 h / -20 °C
1.2: 1 h / 0 °C
2.1: manganese(IV) oxide / dichloromethane / 5 h
3.1: ammonia / ethanol / 5 h / 0 °C
4.1: hydrazine hydrate / ethanol / 1 h / 20 °C
5.1: caesium carbonate / N,N-dimethyl-formamide / 12 h / 100 °C
6.1: hydrogenchloride / methanol / 2 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: magnesium; iodine / tetrahydrofuran / 40 °C / Inert atmosphere
1.2: 0 - 25 °C
2.1: potassium hydroxide; palladium on activated charcoal / 1,4-dioxane / Inert atmosphere; Reflux
3.1: triphenylphosphine; di-isopropyl azodicarboxylate / tetrahydrofuran / 25 h / 0 - 30 °C
View Scheme
Multi-step reaction with 3 steps
1.1: n-butyllithium / tetrahydrofuran / 1 h / -78 - -65 °C / Inert atmosphere
1.2: 3 h / -60 - 0 °C
2.1: (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium carbonate / 1,4-dioxane; water / 80 °C / Inert atmosphere
3.1: trifluoroacetic acid / dichloromethane / 20 °C
View Scheme
(4,6-dichloropyrimidin-5-yl)(4-phenoxyphenyl)methanol

(4,6-dichloropyrimidin-5-yl)(4-phenoxyphenyl)methanol

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: manganese(IV) oxide / dichloromethane / 5 h
2: ammonia / ethanol / 5 h / 0 °C
3: hydrazine hydrate / ethanol / 1 h / 20 °C
4: caesium carbonate / N,N-dimethyl-formamide / 12 h / 100 °C
5: hydrogenchloride / methanol / 2 h / 20 °C
View Scheme
(4,6-dichloropyrimidin-5-yl)(4-phenoxyphenyl)methanone

(4,6-dichloropyrimidin-5-yl)(4-phenoxyphenyl)methanone

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: ammonia / ethanol / 5 h / 0 °C
2: hydrazine hydrate / ethanol / 1 h / 20 °C
3: caesium carbonate / N,N-dimethyl-formamide / 12 h / 100 °C
4: hydrogenchloride / methanol / 2 h / 20 °C
View Scheme
(4-amino-6-chloropyrimidin-5-yl)(4-phenoxyphenyl)methanone

(4-amino-6-chloropyrimidin-5-yl)(4-phenoxyphenyl)methanone

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrazine hydrate / ethanol / 1 h / 20 °C
2: caesium carbonate / N,N-dimethyl-formamide / 12 h / 100 °C
3: hydrogenchloride / methanol / 2 h / 20 °C
View Scheme
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

2-chloropropionyl chloride
625-36-5

2-chloropropionyl chloride

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-1-piperidin-1-yl)-3-chloropropyl-1-one

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-1-piperidin-1-yl)-3-chloropropyl-1-one

Conditions
ConditionsYield
With sodium hydrogencarbonate In tetrahydrofuran at -20℃; for 3h; Concentration; Reagent/catalyst; Solvent; Temperature; Inert atmosphere;99%
With sodium acetate In water at 5 - 15℃; for 1h; Reagent/catalyst; Solvent; Inert atmosphere;94.9%
Stage #1: (R)-3-(4-phenoxyphenyl)-1-(piperidine-3-yl)-1H-pyrazolo[3,4-d]pyrimidine-4-amine With 2,6-di-tert-butyl-4-methyl-phenol In 2-methyltetrahydrofuran at 10℃; for 0.333333h;
Stage #2: 2-chloropropionyl chloride With sodium hydrogencarbonate In 2-methyltetrahydrofuran; water at 10℃; for 3h; Reagent/catalyst; Temperature; Inert atmosphere;
87.9%
With N-ethyl-N,N-diisopropylamine In dichloromethane at -20 - -10℃; Inert atmosphere;830 mg
With sodium hydrogencarbonate In 2-methyltetrahydrofuran; water
3-bromopropionyl bromide
7623-16-7

3-bromopropionyl bromide

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-1-piperidin-1-yl)-3-bromopropyl-1-one

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-1-piperidin-1-yl)-3-bromopropyl-1-one

Conditions
ConditionsYield
In tetrahydrofuran at -20℃; for 3h; Inert atmosphere;99%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

1-[2-(4-tert-butoxycarbonylpiperazin-1-yl)pyrimidin-5-yl]piperidine-4-carboxylic acid

1-[2-(4-tert-butoxycarbonylpiperazin-1-yl)pyrimidin-5-yl]piperidine-4-carboxylic acid

tert-butyl 4-[5-[4-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-1-piperidyl]pyrimidin-2-yl]piperazine-1-carboxylate

tert-butyl 4-[5-[4-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-1-piperidyl]pyrimidin-2-yl]piperazine-1-carboxylate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 20℃; for 3h;99%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

cyanoacetic acid
372-09-8

cyanoacetic acid

(R)-3-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)(3-keto)propionitrile
1412418-10-0

(R)-3-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)(3-keto)propionitrile

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 2h; Cooling with ice;95%
Stage #1: cyanoacetic acid With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane for 0.166667h; Cooling with ice;
Stage #2: (R)-3-(4-phenoxyphenyl)-1-(piperidine-3-yl)-1H-pyrazolo[3,4-d]pyrimidine-4-amine In dichloromethane at 20℃; for 2h; Cooling with ice;
95%
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide90%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(2E)‐4‐[4‐(2‐{[(tert‐butoxy)carbonyl]amino}ethyl)piperazin‐1‐yl]but‐2‐enoic acid

(2E)‐4‐[4‐(2‐{[(tert‐butoxy)carbonyl]amino}ethyl)piperazin‐1‐yl]but‐2‐enoic acid

tert-butyl (R,E)-(2-(4-(4-(3-(4-amino-3-(4-phenoxyphenyl)-1Hpyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-4-oxobut-2-en-1-yl)piperazin-1-yl)ethyl)carbamate

tert-butyl (R,E)-(2-(4-(4-(3-(4-amino-3-(4-phenoxyphenyl)-1Hpyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-4-oxobut-2-en-1-yl)piperazin-1-yl)ethyl)carbamate

Conditions
ConditionsYield
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide Inert atmosphere;87%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

5-chloro-1H-benzo[d][1,2,3]triazol-1-yl acrylate

5-chloro-1H-benzo[d][1,2,3]triazol-1-yl acrylate

ibrutinib

ibrutinib

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 0 - 30℃; for 1h;86.64%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]octanoic acid

8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]octanoic acid

C43H45N9O6

C43H45N9O6

Conditions
ConditionsYield
With dmap; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 20℃; for 12h;86%
With dmap; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 20℃; for 12h;86%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

(R)-1-(1-(methylsulfonyl)piperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-1-(1-(methylsulfonyl)piperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃;85%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

9-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino]nonanoic acid

9-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino]nonanoic acid

C44H47N9O6

C44H47N9O6

Conditions
ConditionsYield
With dmap; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 20℃; for 12h;85%
With dmap; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 20℃; for 12h;85%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Ethanesulfonyl chloride
594-44-5

Ethanesulfonyl chloride

(R)-1-(1-(ethylsulfonyl)piperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-1-(1-(ethylsulfonyl)piperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃;83%
n-propanesulfonyl chloride
10147-36-1

n-propanesulfonyl chloride

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-3-(4-phenoxyphenyl)-1-(1-(propylsulfonyl)piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-3-(4-phenoxyphenyl)-1-(1-(propylsulfonyl)piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃;83%
3,3-dimethylbutanoic acid chloride
7065-46-5

3,3-dimethylbutanoic acid chloride

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3,3-dimethylbutan-1-one

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3,3-dimethylbutan-1-one

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃;82%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

cyclopropanecarboxylic acid chloride
4023-34-1

cyclopropanecarboxylic acid chloride

(R)-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)(cyclopropyl)methanone

(R)-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)(cyclopropyl)methanone

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃;82%
(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1022150-12-4

(R)-3-(4-phenoxyphenyl)-1-(1-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

ibrutinib

ibrutinib

Conditions
ConditionsYield
With zirconium(IV) tert-butoxide; benzotriazol-1-ol In toluene at 60℃; for 12h; Temperature;82%

1022150-12-4Relevant articles and documents

A synthetic method of ibutinib

-

, (2022/03/02)

The present invention provides a preparation method of ibutinib and its application, by optimizing the feeding ratio and reaction conditions, increasing the purification step of the intermediate, and the use of inorganic alkali instead of organic base as an acid binding agent, significantly reducing the impurity content of ibutinib synthetic intermediates and final products, especially the content of isomer impurities, to ensure the quality of drugs and clinical drug safety provides a strong guarantee.

PROCESSES AND INTERMEDIATES FOR PREPARING A BTK INHIBITOR

-

, (2020/12/07)

Disclosed is a process for the preparation of certain intermediates, e.g. a process for preparing a compound of formula (I) wherein, R1, R2 and X1 are as defined in the description, and which intermediate and processes are useful in the preparation of a BTK inhibitor, such as ibrutinib.

Preparation method of precursor of ibrutinib

-

, (2020/04/22)

The invention relates to the pharmaceutical industry, in particular to a preparation method of a drug intermediate, and specifically discloses a preparation method of a precursor of ibrutinib. The preparation method comprises the following steps: (1) reacting a compound (III) with triphenylphosphine and azodicarbonic acid diester to obtain an intermediate (III-B); (2) reacting the intermediate (III-B) with a compound (IV) under the action of a catalyst to obtain an intermediate (V-C); and (3) reacting the intermediate (V-C) under the action of hydrochloric acid to obtain (R)-3-(4-phenoxy phenyl)-1-(piperidine-3-yl)-1H-pyrazolo [3, 4-d] pyrimidine-4-amine (I). The method has the advantages of high yield, high purity, convenience in purification, simplicity and convenience in operation and the like, is suitable for industrial production, and contributes to reducing the cost to a certain extent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1022150-12-4